Brief: Ocumension Therapeutics Says Unit Entered Collaboration & Exclusive Promotion Deal With Shandong Boan Biotechnology
29/10/2020 23:05
Oct 30 (Reuters) - Ocumension Therapeutics 1477.HK :
* UNIT ENTERED COLLABORATION & EXCLUSIVE PROMOTION DEAL WITH
SHANDONG BOAN BIOTECHNOLOGY
Source text for Eikon: urn:newsml:reuters.com:*:nHKS7wy2md
Further company coverage: 1477.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Ocumension Therapeutics
See all newsBrief: Ocumension Therapeutics Says NMPA Accepts NDA For OT-301 (NCX 470, Bimatoprost Grenod)
Brief: Ocumension Therapeutics Says Dexamethasone Intraocular Suspension Application Accepted By NMPA
Brief: Ocumension Therapeutics Says HY Adjusted Net Loss Rmb57.5 Million
China's Ocumension Therapeutics H1 revenue surges on higher ophthalmic product sales
Ocumension jumps most in three months on China nod for new drug application